|
Volume 272, Number 23,
Issue of June 6, 1997
pp. 14586-14591
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Evidence for the Direct Involvement of Transmembrane Region 6 of
the Lutropin/Choriogonadotropin Receptor in Activating
Gs
(Received for publication, October 25, 1996, and in revised form, March 5, 1997)
Amy N.
Abell
and
Deborah L.
Segaloff
From the Department of Physiology and Biophysics, University of
Iowa College of Medicine, Iowa City, Iowa 52242
The luteinizing hormone/chorionic gonadotropin
receptor (LHR) is a heptahelical receptor that interacts primarily with
Gs. Previous studies by others have shown that some
forms of familial male precocious puberty are associated with mutations
of the human LHR in the sixth transmembrane region that result in
constitutive activation of the receptor. This study demonstrates that a
peptide corresponding to the lower portion of the sixth transmembrane region of the LHR can significantly activate adenylyl cyclase activity.
Experiments with membranes derived from wild-type versus cyc S49 cells demonstrate that the stimulation of
cyclase by this peptide is due to an activation of Gs. As
such, our data demonstrate a direct role for transmembrane region 6 of
the rat LHR in activating Gs and therefore raise the
possibility that mutations in transmembrane region 6 of the LHR may
directly affect the coupling of the receptor to Gs.
Significantly, these data are the first to demonstrate the ability of a
transmembrane portion of a G protein-coupled receptor, in the absence
of any contributions from an intracellular loop region, to activate a G
protein.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
U. Ringkananont, J. Van Durme, L. Montanelli, F. Ugrasbul, Y. M. Yu, R. E. Weiss, S. Refetoff, and H. Grasberger
Repulsive Separation of the Cytoplasmic Ends of Transmembrane Helices 3 and 6 Is Linked to Receptor Activation in a Novel Thyrotropin Receptor Mutant (M626I)
Mol. Endocrinol.,
April 1, 2006;
20(4):
893 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sangkuhl, A. Schulz, G. Schultz, and T. Schoneberg
Structural Requirements for Mutational Lutropin/Choriogonadotropin Receptor Activation
J. Biol. Chem.,
November 27, 2002;
277(49):
47748 - 47755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ji, C. Lee, Y. Song, P. M. Conn, and T. H. Ji
Cis- and Trans-Activation of Hormone Receptors: the LH Receptor
Mol. Endocrinol.,
June 1, 2002;
16(6):
1299 - 1308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ascoli, F. Fanelli, and D. L. Segaloff
The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective
Endocr. Rev.,
April 1, 2002;
23(2):
141 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Y.-Y. Chan, R. T.-K. Pang, and B. K.-C. Chow
Functional Segregation of the Highly Conserved Basic Motifs within the Third Endoloop of the Human Secretin Receptor
Endocrinology,
September 1, 2001;
142(9):
3926 - 3934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Neumann, G. Krause, S. Chey, and R. Paschke
A Free Carboxylate Oxygen in the Side Chain of Position 674 in Transmembrane Domain 7 Is Necessary for TSH Receptor Activation
Mol. Endocrinol.,
August 1, 2001;
15(8):
1294 - 1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shinozaki, F. Fanelli, X. Liu, J. Jaquette, K. Nakamura, and D. L. Segaloff
Pleiotropic Effects of Substitutions of a Highly Conserved Leucine in Transmembrane Helix III of the Human Lutropin/Choriogonadotropin Receptor with Respect to Constitutive Activation and Hormone Responsiveness
Mol. Endocrinol.,
June 1, 2001;
15(6):
972 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mukherjee, K. Palczewski, V. V. Gurevich, and M. Hunzicker-Dunn
beta -Arrestin-dependent Desensitization of Luteinizing Hormone/Choriogonadotropin Receptor Is Prevented by a Synthetic Peptide Corresponding to the Third Intracellular Loop of the Receptor
J. Biol. Chem.,
May 7, 1999;
274(19):
12984 - 12989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schulz, T. Schöneberg, R. Paschke, G. Schultz, and T. Gudermann
Role of the Third Intracellular Loop for the Activation of Gonadotropin Receptors
Mol. Endocrinol.,
February 1, 1999;
13(2):
181 - 190.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K.-S. Min, X. Liu, J. Fabritz, J. Jaquette, A. N. Abell, and M. Ascoli
Mutations That Induce Constitutive Activation and Mutations That Impair Signal Transduction Modulate the Basal and/or Agonist-stimulated Internalization of the Lutropin/Choriogonadotropin Receptor
J. Biol. Chem.,
December 25, 1998;
273(52):
34911 - 34919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Abell, D. J. McCormick, and D. L. Segaloff
Certain Activating Mutations within Helix 6 of the Human Luteinizing Hormone Receptor May Be Explained by Alterations That Allow Transmembrane Regions to Activate Gs
Mol. Endocrinol.,
December 1, 1998;
12(12):
1857 - 1869.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Wonerow, T. Schoneberg, G. Schultz, T. Gudermann, and R. Paschke
Deletions in the Third Intracellular Loop of the Thyrotropin Receptor. A NEW MECHANISM FOR CONSTITUTIVE ACTIVATION
J. Biol. Chem.,
April 3, 1998;
273(14):
7900 - 7905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Latronico, Y. Chai, I. J.P. Arnhold, X. Liu, B. B. Mendonca, and D. L. Segaloff
A Homozygous Microdeletion in Helix 7 of the Luteinizing Hormone Receptor Associated with Familial Testicular and Ovarian Resistance Is Due to Both Decreased Cell Surface Expression and Impaired Effector Activation by the Cell Surface Receptor
Mol. Endocrinol.,
March 1, 1998;
12(3):
442 - 450.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Schulz, K. Bruns, P. Henklein, G. Krause, M. Schubert, T. Gudermann, V. Wray, G. Schultz, and T. Schoneberg
Requirement of Specific Intrahelical Interactions for Stabilizing the Inactive Conformation of Glycoprotein Hormone Receptors
J. Biol. Chem.,
November 22, 2000;
275(48):
37860 - 37869.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|